# SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

> **NCT05869968** · — · ACTIVE_NOT_RECRUITING · sponsor: **Northwell Health** · enrollment: 140 (estimated)

## Conditions studied

- Spinal Cord Injuries
- Traumatic Spinal Cord Injury
- Healthy Controls
- Flu Vaccine
- COVID-19 Vaccine

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05869968
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-31
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05869968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05869968, "SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05869968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*